Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock-Reference-Cited by-同舟云学术

Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock

Published:2018-09 Issue:9 Volume:46 Page:e874-e880
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Gaubert Mélanie,Marlinge Marion,Kerbaul François,Resseguier Noemie,Laine Marc,Cautella Jennifer,Cordier Charlotte,Colomb Benjamin,Kipson Nathalie,Thuny Franck,Mottola Giovanna,Fenouillet Emmanuel,Ruf Jean,Paganelli Franck,Guieu Régis,Bonello Laurent

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference40 articles.

1. Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction

2. Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997–2012

3. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French Nationwide Registries

4. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States

5. Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and toxicity evaluation of natural compounds as adenosine 2a and 2b receptor ligands: insights from molecular docking, dynamics, and ADMET analysis;Drug and Chemical Toxicology;2024-08-20

2. Adenosine signaling as target in cardiovascular pharmacology;Current Opinion in Pharmacology;2023-08

3. Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause;Therapeutic Advances in Reproductive Health;2023-01

4. Adenosine and Adenosine Receptors: Advances in Atrial Fibrillation;Biomedicines;2022-11-17

5. Adenosine Receptors Profile in Fibromuscular Dysplasia;Biomedicines;2022-11-06